(2E)-3-(3-bromo-4-methoxyphenyl)acrylic acid, 95.0%, 25g

Ethyl 2-((5-chloropyridin-2-yl)amino)-2-oxoacetate hydrochloride, 95.0%, 10g

(S)-N-(2-((1-benzylpyrrolidin-3-yl)amino)-2-oxoethyl)-3-(trifluoromethyl)benzamide, 98%, 50mg

5-Amino-2-chloronicotinic acid, 97.0%, 10g

2,6-Dibromo-4-fluorobenzo[d]thiazole, 97%, 250mg

Condenseur à serpentin, 160 mm, 14/23, 1 pièce

3-Methylisothiazole, 95.0%, 100mg

N-cyclopropyl-N-(piperidin-4-yl)methanesulfonamide, 95.0%, 250mg

PYRAZOLO[1,5-A]PYRIDINE-5-CARBOXYLIC ACID, 95.0%, 5g

Methyl-�-D-glucopyranoside hemihydrate, 98.0%, 5g

5-Oxo-5-(3-thiomethylphenyl)valeric acid, 97.0%, 1g

1-Cbz-(2R)-Methylpiperazine, 97.0%, 100g

1H,1H,11H-Eicosafluoro-1-undecanol, 85.0%, 500g